Last reviewed · How we verify
NCT06733181: REMINDER
The REMINDER Program for Older Adults Supported by Residential and Daycare Facilities
NA trial testing REMINDER intervention in Aging, Healthy in 25 participants. Completed in 26 October 2024.
31 July 2024
Quick facts
| Lead sponsor | University of Coimbra |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 25 |
| Start date | 20 July 2023 |
| Primary completion | 31 July 2024 |
| Estimated completion | 26 October 2024 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- REMINDER intervention
Conditions studied
- Aging, Healthy — all drugs for Aging, Healthy →
- Risk Reduction — all drugs for Risk Reduction →
- Old Age; Dementia — all drugs for Old Age; Dementia →
Sponsor
University of Coimbra
Who can join
65 and older, any sex, with Aging, Healthy or Risk Reduction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Dementia and mild cognitive impairment (MCI) deeply impact individuals' well-being and are expected to increase due to population aging, with global cases projected to rise to 152.8 million by 2050. Social isolation, accounting for 4% of dementia cases, emerges as a critical modifiable risk factor, particularly in institutionalized older adults, where it significantly raises dementia risk. To address these challenges, the REMINDER program was developed as a tailored, multidomain intervention to reduce dementia risk, emphasizing social and cognitive engagement and advancing its adaptation and evaluation in Residential and Daycare Facilities (RDF). To assess the feasibility of REMINDER in older adults supported by RDF (recruitment, adherence, retention, acceptability, accessibility, and usability) and explore potential changes in cognitive and psychosocial outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06733181
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aging, Healthy
Currently open trials in the same condition.
- NCT07442097 — Safe-Age Study: A Safety and Tolerability Study of a Nutritional Supplement in Healthy Older Adults · NA · recruiting
- NCT07275424 — Study of Healthy Aging and Physical Function With Elamipretide · Phase 2 · recruiting
- NCT07203196 — Circadian Health Regulation and Optimization for Rejuvenation Outcomes · NA · active not recruiting
- NCT06726616 — Physical and Cognitive Aging Study in Older Adults · recruiting
Other University of Coimbra trials
Trials by the same sponsor.
- NCT07018089 — The Efficacy of the iWork.COMP Among Health Care Professionals · NA · not yet recruiting
- NCT07481253 — PSYCHOPATHY.COMP Program Among Male Prison Inmates With Psychopathy · NA · not yet recruiting
- NCT07296081 — ⁶⁸Ga-FAPI PET/CT for Cardiac Fibrosis in Heart Failure · recruiting
- NCT07329647 — Targeting Neurovascular Coupling in Cognitive Decline Via Nitrate-Based Supplementation · NA · recruiting
- NCT06922071 — The REMINDER4Care Program for Older Adults Supported by Residential and Daycare Facilities · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06733181 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Coimbra
- Last refreshed: 23 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06733181.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing